Two Hypomorphic Alleles of Mouse Ass1 as a New Animal Model of Citrullinemia Type I and Other Hyperammonemic Syndromes

    Claudio F. Pérez, Jean Jaubert, Jean-Louis Guénet, Kirstin Barnhart, Catherine Ross-Inta, Vicente C. Quintanilla, Isabelle Aubin, Jimi L. Brandon, Nancy Otto, John DiGiovanni, Irma Gimenez-Conti, Cecilia R Giulivi, Donna F. Kusewitt, Claudio J. Conti, Fernando Benavides
    Image of study
    TLDR Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.
    Researchers developed two hypomorphic alleles of the mouse Ass1 gene, named barthez (bar) and follicular dystrophy (fold), creating a new animal model for Citrullinemia Type I (CTLN1) and other hyperammonemic syndromes. These mutations led to a range of phenotypes, including early death, severe developmental retardation, alopecia, lethargy, and ataxia, mirroring human CTLN1 symptoms. Plasma analysis showed elevated citrulline and ammonia levels, and histological examination revealed epidermal hyperplasia and hyperkeratosis. Standard CTLN1 treatments, such as arginine supplementation and nitrogen scavengers, were effective in rescuing the mutant phenotype. This model provided valuable insights into CTLN1 pathophysiology and therapeutic approaches.
    Discuss this study in the Community →